Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 204.77
+6.17 (3.11%)
Jun 19, 2026, 3:30 PM IST
Hikal Market Cap
Hikal has a market cap or net worth of 25.31 billion as of June 18, 2026. Its market cap has decreased by -44.92% in one year.
Market Cap
25.31B
Enterprise Value
32.01B
Revenue
17.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
204.77
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 25.31B, an increase of 1,764.67%. That is a compound annual growth rate of 12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 25.31B | -9.54% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 59.70B |
| Innova Captab | 53.50B |
| Orchid Pharma | 51.14B |
| RPG Life Sciences | 38.07B |
| Solara Active Pharma Sciences | 27.34B |
| Indoco Remedies | 21.34B |
| Beta Drugs | 18.89B |
| Sakar Healthcare | 17.83B |